Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Multiple Indications”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableWithdrawnNCT03161613
What this trial is testing

Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico

Who this might be right for
Multiple Indications Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)UnknownNCT03018405
What this trial is testing

A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications

Who this might be right for
Acute Myeloid Leukemia/Myelodysplastic SyndromeMultiple Myeloma (MM)
Celyad Oncology SA 146
Large-scale testing (Phase 3)Not Yet RecruitingNCT07440290
What this trial is testing

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+16 more
Cancer Research UK 30
Large-scale testing (Phase 3)Looking for participantsNCT03829553
What this trial is testing

Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment

Who this might be right for
Breast Cancer
Ruijin Hospital 801
Early research (Phase 1)Study completedNCT02517398
What this trial is testing

MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 600
Large-scale testing (Phase 3)Study completedNCT00522951
What this trial is testing

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Who this might be right for
Brain Metastases
Bayer 165
Testing effectiveness (Phase 2)Study completedNCT04143711
What this trial is testing

Study of DF1001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 270
Early research (Phase 1)Study completedNCT00729664
What this trial is testing

Multiple Ascending Dose (MDX1105-01)

Who this might be right for
Cancer, Multiple Indications
Bristol-Myers Squibb 281
Early research (Phase 1)Study completedNCT03102320
What this trial is testing

Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors

Who this might be right for
Neoplasms
Bayer 173
Not applicableLooking for participantsNCT01351545
What this trial is testing

Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Who this might be right for
Hematologic MalignanciesInherited Disorders of MetabolismInherited Abnormalities of Platelets+14 more
Center for International Blood and Marrow Transplant Research 99,999
Not applicableUnknownNCT02577627
What this trial is testing

Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung CancerProstate Cancer+2 more
Optimata Ltd. 5,000
Testing effectiveness (Phase 2)WithdrawnNCT01479582
What this trial is testing

Providing Access to Cord Blood Units for Transplants

Who this might be right for
Chronic Myelogous Leukemia/Other LeukemiaAcute LeukemiasMDS/MPS+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02297139
What this trial is testing

Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib

Who this might be right for
Multiple Indications Cancer
Bristol-Myers Squibb 17
Not applicableStudy completedNCT01294722
What this trial is testing

Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea

Who this might be right for
Rheumatoid Arthritis
Janssen Korea, Ltd., Korea 1,700
Not applicableWithdrawnNCT03983486
What this trial is testing

Rationale for Cytogenetic Risk Stratification by Imaging Flow Cytometry in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire, Amiens
Early research (Phase 1)Study completedNCT03523390
What this trial is testing

Phase I/Ib Multiple Ascending Dose Study in China

Who this might be right for
Metastatic Solid Tumors
Merck KGaA, Darmstadt, Germany 24
Testing effectiveness (Phase 2)Looking for participantsNCT04817956
What this trial is testing

Improving Public Cancer Care by Implementing Precision Medicine in Norway

Who this might be right for
Cancer Metastatic
Oslo University Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT05597839
What this trial is testing

Study of DF9001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 24
Not applicableLooking for participantsNCT07295171
What this trial is testing

HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG

Who this might be right for
Multiple CancersMultiple Indications CancerFeasibility Studies
British Columbia Cancer Agency 27
Large-scale testing (Phase 3)Looking for participantsNCT04513639
What this trial is testing

The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study

Who this might be right for
Multiple Myeloma
Oslo University Hospital 176
Load More Results